Conference Coverage
Conference Coverage
BC axillary dissection may be unnecessary for isolated tumor cells after NAC
A large study has addressed a key question in breast cancer surgery: what to do when isolated tumor cells are found in sentinel lymph nodes after...
Conference Coverage
Nodal Radiation May Make BC Axillary Dissection Unnecessary
A major trial finds that there’s no need to do both in breast cancer patients with just one or two positive sentinel lymph nodes.
Conference Coverage
Survival-Toxicity Trade-off With T-DM1 in HER+ Breast Cancer
Older patients with advanced HER2+ breast cancer do not experience a survival benefit with trastuzumab emtansine vs standard-of-care combination...
Conference Coverage
Pregnancy safe after BRCA-mutated breast cancer
Although pregnancy after breast cancer is considered safe in general, little data exist for BRCA carriers.
Conference Coverage
Patients with HR-positive breast cancer can safely use ART
“These data are reassuring for our young patients with a diagnosis of breast cancer and shows that assisted reproductive technology is an option...
Conference Coverage
Less is more for axillary surgery in early breast cancer
Women with early breast cancer can safely undergo less extensive axillary surgery because it has no impact on recurrence or mortality rate.
Conference Coverage
Few with inflammatory breast cancer get guideline-based care
A retrospective study of patients with inflammatory breast cancer shows that the majority of patients don’t receive guideline-based care.
Conference Coverage
‘Baby TAM’ effective, tolerable for breast cancer prevention
A new study shows that a lower dose of tamoxifen leads to better adherence, and another shows similar efficacy at reducing breast density.
Conference Coverage
Living in a Food Swamp Tied to High Breast Cancer Mortality
New research shows higher postmenopausal breast cancer mortality in communities with easier access to unhealthy fast food.
Conference Coverage
Oncotype Score Helps Avoid Unnecessary Radiation in DCIS
Using a gene test to guide radiation decisions may reduce overtreatment in ductal carcinoma in situ.